ArticleBMJ open2025

Efficacy and safety of microbiota-targeted therapeutics in autoimmune and inflammatory rheumatic diseases: protocol for a systematic review and meta-analysis of randomised controlled trials.

Maja Skov Kragsnaes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.